arqule.com
ArQule | Small Molecules for Precision MedicineWe are pursuing multiple programs in biomarker-defined oncology and rare disease indications
http://www.arqule.com/
We are pursuing multiple programs in biomarker-defined oncology and rare disease indications
http://www.arqule.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
4.9 seconds
Arqule, Inc
19 Pre●●●●●●al Way
Wo●●rn , MA, 01801
US
View this contact
ArQule, Inc.
Admins, Network
19 PRE●●●●●●AL WAY
WO●●RN , MA, 01801-1040
US
View this contact
ArQule, Inc.
Admins, Network
19 PRE●●●●●●AL WAY
WO●●RN , MA, 01801-1040
US
View this contact
BUY YOUR DOMAIN
28
YEARS
7
MONTHS
17
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
3
SSL
EXTERNAL LINKS
131
SITE IP
45.79.167.110
LOAD TIME
4.922 sec
SCORE
6.2
ArQule | Small Molecules for Precision Medicine | arqule.com Reviews
https://arqule.com
We are pursuing multiple programs in biomarker-defined oncology and rare disease indications
Investor & Media | ArQule, Inc.
Skip to main navigation. Rare Diseases Clinical Trials. Investor and Media FAQs. Investor and Media Contact. ArQule is led by a senior management team with significant clinical and commercial expertise that provides the leadership required to optimize its opportunities for success in a rapidly changing and highly competitive field. ArQule is listed on NASDAQ and trades under the ticker ARQL. Mar 20, 2018. ArQule to Present at the 17th Annual Needham Healthcare Conference on March 27, 2018. Mar 15, 2018.
arqule.com
ArQule | Results from a Phase 1 Study of ARQ 092, a Novel Pan AKT-Inhibitor, in Subjects with Advanced Solid Tumors or Recurrent Malignant Lymphoma
https://www.arqule.com/res
News & Events. BTK Inhibitor (ARQ 531). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Events & Presentations. Investor & Media FAQs. Investor & Media Contact. Results from a Phase 1 Study of ARQ 092, a Novel Pan AKT-Inhibitor, in Subjects with Advanced Solid Tumors or Recurrent Malignant Lymphoma. Tuesday, September 1, 2015 Posters and Presentations. Please feel free to contact by one of the methods below. News & Events. Rare Diseases Clinical Trials.
ArQule | Contact
https://www.arqule.com/cont
News & Events. BTK Inhibitor (ARQ 531). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Events & Presentations. Investor & Media FAQs. Investor & Media Contact. Burlington, MA 01803. Senior Director, Investor Relations/Corporate Communications. Senior Director, Business Development and Alliance Management. Senior Director, Investor Relations/Corporate Communications. Senior Manager, Human Resources. News & Events. Please feel free to contact by one of the methods below.
ArQule | About
https://www.arqule.com/abo
News & Events. BTK Inhibitor (ARQ 531). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Events & Presentations. Investor & Media FAQs. Investor & Media Contact. Small Molecules for Precision Medicine. ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases. Is an oral selective and potent pan-AKT inhibitor that inhibits both wild-type and mutant AKT1, currently in development for onco...
TOTAL PAGES IN THIS WEBSITE
3
Clients - Bioscience Valuation
http://www.bioscience-valuation.com/clients.php
Through its 'Corporate Partnership Program', Bioscience Valuation has provided exceptional support in the tranformation of our business model. BSV's evidence-based assessments proved invaluable for our strategic decision making as well as for preparing our corporate transactions. ”. Peter Llewellyn-Davies, CFO/CBO. R&D Risk Analysis &. Corporate Finance / M&A. Healthcare / Life Science. Cell Technologies, s.l. Aesculap AG and Co. KG. AiCuris GmbH and Co. KG. Alternative Gene Expression S.L.
ArQule, Inc. | Events & Presentations
http://investors.arqule.com/events.cfm
News & Events. Second Generation AKT Inhibition (ARQ 751). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Investor and Media FAQs. Investor and Media Contact. Aug 3, 2016. Q2 2016 ArQule, Inc. Earnings Conference Call. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Aug 3, 2016. File is in Briefcase. Aug 3, 2016. AKT Program ARQ 092 and ARQ 751. AKT Program ARQ 092 and ARQ 751. File is in Briefcase. Aug 3, 2016.
Wendy Warr & Associates
http://www.warr.com/links.html
Title (click on the link to view the section). Chemical Libraries and Samples. Some Biopharmaceutical Companies and Pharmaceutical Industry Partners. Software Systems, Integration, Consultants. Societies, communities and miscellaneous links. CHEMICAL LIBRARIES AND SAMPLES. Association of Chemical Laboratories of Universities of St.-Petersburg (SPBU). Biotechnology Corporation of America. Chemical Technologies and Investigations. Florida Center for Heterocyclic Compounds. LCC Engineering and Trading.
See Our Portfolio
http://www.valencefund.com/portfolio
Dr Dani P. Bolognesi, Ph.D. Robert R. Bonczek, J.D. Peter R. Dolan. Dr Henry A. McKinnell, Ph.D. A public cardiovascular and inflammatory disease company. A public company focused on targeted cancer therapeutics. A public company focused on optimizing the combination of proven cancer therapies. A private company developing the hormone, Relaxin, in acute heart failure - acquired by Novartis, originally Corthera. Invuity's products enable less invasive surgery using proprietary photonic solutions. Celator ...
ArQule, Inc. | Financial Information
http://investors.arqule.com/financials.cfm
News & Events. Second Generation AKT Inhibition (ARQ 751). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Investor and Media FAQs. Investor and Media Contact. Second Quarter 2016 Financial Results. ArQule Reports Second Quarter 2016 Financial Results. File is in Briefcase. Q2 2016 ArQule, Inc. Earnings Conference Call. 2015 Annual Report on Form 10-K. File is in Briefcase. 2014 Annual Report on Form 10-K. File is in Briefcase. Apr 14, 2016. File is in Briefcase.
ArQule, Inc. | Download Library
http://investors.arqule.com/downloads.cfm
News & Events. Second Generation AKT Inhibition (ARQ 751). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Investor and Media FAQs. Investor and Media Contact. 2015 Annual Report on Form 10-K. File is in Briefcase. File is in Briefcase. File is in Briefcase. Tivantinib ILCA 2015 ePoster- Phase 3 METIV-HCC Design.pdf. File is in Briefcase. Tivantinib ILCA 2015 Oral Presentation - Phase 2 HCC Biomarker Analysis.pdf. File is in Briefcase. 2014 Annual Report on Form 10-K.
ArQule, Inc. |
http://investors.arqule.com/eventdetail.cfm?EventID=162811
News & Events. Second Generation AKT Inhibition (ARQ 751). Rare Diseases Clinical Trials. Publications & Presentations. Investors & Media. Investor and Media FAQs. Investor and Media Contact. I Decline, take me back to the previous page. Investor and Media FAQs. Investor and Media Contact. Please feel free to contact by one of the methods below. Rare Diseases Clinical Trials. Second Generation AKT Inhibition (ARQ 751). Investor and Media FAQs. Investor and Media Contact. What are you looking for?
Robert E. Wells Resume
http://www.wellscs.com/robert/robresum.htm
Robert E. Wells. Palo Alto, CA 94306. Software Project Leader / Architect / Senior Developer. 15 years experience building innovative software systems that solve business problems effectively. Enthusiastic and passionate about building excellent software, and building great teams. Very rapid learner, voracious reader, good listener, effective writer and speaker, extremely organized and disciplined, good people skills. Current focus on web-based distributed applications in Java, JBoss. Familiar with Micro...
TOTAL LINKS TO THIS WEBSITE
131
Arquivet. Productos para mascotas y animales de compañía.
Tel: 902 656 084. Descarga el catálogo de novedades. Arquivet productos para mascotas. Cama higiénica de Arquivet con aroma a Rosas. La nueva cama higiénica de Arquivet con aroma a Rosas, absorbe los malos olores, tiene una gran capacidad absorbente, tiene actividad bactericida, es atóxica y completamente biodegradable. Gammarus sticks, alimento para tortugas acuáticas. Gammarus, alimento para tortugas acuáticas. Contenant : viande de poulet, farine de poisson, céréales extraits de protéines végétales, h...
幸运千里视像科技集团股份有限公司
VR手机 智能视讯会议系统 大宝机器人 魔镜. 合众宝 智能驾驶系列产品 小宝机器人 缤纷. 乐摇宝 神灯机器人 魔镜机器人 夜单. 近日，保千里集团旗下全资子公司深圳市保千里电子有限公司 以下简称“保千里” 与江西汉腾汽车有限公司 以下简称“汉腾汽车” 于近日签署了汽车. 保千里积极布局智能硬件 战略，研发生产了VR手机、合众宝、乐摇宝、智能机器人、车载宝、智会宝、智能网联汽车等应用于个人移动端、家庭、实体企业、实体商店、公共场所、汽车的平台型智能硬件终端，为客户提供“智能硬件 互联网 新媒体”模式的全营销解决方案，智联传统产业，创造智慧生活。 媒体垂询 media#protruly.com.cn(请将#替换成@).
Arquiz Arquitectura Zuleta Arquitectos Panamá
arquland83's blog - arquland83 - Skyrock.com
19/01/2007 at 4:19 AM. 19/03/2007 at 7:54 AM. Subscribe to my blog! Posted on Friday, 19 January 2007 at 5:33 AM. Pa chere le join. Pk il en mette pa de prtt lol. Posted on Friday, 19 January 2007 at 5:32 AM. Posted on Friday, 19 January 2007 at 5:10 AM. Le film ki t nike ta mere. Il et rella ce film. Posted on Friday, 19 January 2007 at 5:03 AM. Et ouai gro tro de fumette. Ces pr les réné. Ki pose leur galette. On passe tt par la. Posted on Friday, 19 January 2007 at 4:58 AM. Post to my blog.
ArQule | Small Molecules for Precision Medicine
News & Events. Rare Diseases Clinical Trials. Patient Access to Investigational Therapies. Publications & Presentations. Investors & Media. Events & Presentations. Investor & Media FAQs. Investor & Media Contact. Small Molecules for Precision Medicine. Learn More about Arqule. We are pursuing multiple programs in biomarker-defined oncology and rare disease indications. Targeted Approach to Cancer. September 29, 2017. Proteus Syndrome Phase 1 Data Presentation. Watch Video ». March 5, 2018. March 15, 2018.
ArQ ULS | Escuela de Arquitectura – Universidad de La Serena
Viernes, Marzo 16, 2018 -. Mapa de Proyectos de Título. Migrantes – Taller 1. Magíster en Diseño de Entornos Sostenibles. Universidad Austral de Chile. Hasta el 15 de enero estarán abiertas las postulaciones al Magíster en Diseño de Entornos Sostenibles de la Facultad …. Proyecto destacado Taller VI – Cine Sub-Suelo. Hábitat III y los desafíos para el desarrollo de las ciudades de la Región de Coquimbo. Taller VII – Proyecto Ganador. Construcción I – Registro de trabajos destacados 2014- 2015- 2016.
base de datos comunitaria
Base de datos comunitaria. Martes, 19 de junio de 2007. Aqui un comprimido con imagenes para la carpeta de teoria,me pidieron que las subiera,si hubiera podido antes lo hubiera hecho,en verdad si quieren imagenes para la carpeta deberian conseguirse los apuntes del profe,que con esos yo he hecho gran parte de la carpeta y evitado perder tiempo recopilando info por inet.bueno,ojala ha alguien le sirva. Http:/ www.4shared.com/file/18200547/1fb4ffcb/renacimiento.html. Viernes, 15 de junio de 2007. Si alguie...
H&Q Blog
The H&Q Blog: The events leading up to the release of the CD H&Q Featuring Arqum Iqbal. H and Q Blog. Wednesday, November 30, 2011. A lot of people were asking me where they could listen to our interview. At Kong MonsterRock last week. So I made a video of it and put it up on. The songs we performed live start at these times:. MonsterRock Interview - 11/19/2011. And 4 other songs from the CD "H&Q" are also played throughout the. Thanks for all the great support! Friday, September 16, 2011. Thanks for eve...
Arqum - Gesellschaft für Arbeitssicherheits-, Qualitäts- und Umweltmanagement mbH
Validiert für den Standort München. Arqum steht für Arbeitssicherheits-, Qualitäts- und Umweltmanagement - und bietet Beratungsleistungen für Unternehmen und Kommunen auf dem Weg zu einer zukunftsfähigen Wirtschaftsweise an. Kernpunkt unserer Dienstleistungen ist die Beratung von Unternehmen zum betrieblichen Umweltschutz. Projektpartner und Auftraggeber sind unter anderem:. Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit. Burgmann Industries GmbH and Co. KG. 1500 - 16.30 Uhr.
Arqum - Gesellschaft für Arbeitssicherheits-, Qualitäts- und Umweltmanagement mbH
Validiert für den Standort München. Arqum steht für Arbeitssicherheits-, Qualitäts- und Umweltmanagement - und bietet Beratungsleistungen für Unternehmen und Kommunen auf dem Weg zu einer zukunftsfähigen Wirtschaftsweise an. Kernpunkt unserer Dienstleistungen ist die Beratung von Unternehmen zum betrieblichen Umweltschutz. Projektpartner und Auftraggeber sind unter anderem:. Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit. Burgmann Industries GmbH and Co. KG. 1500 - 16.30 Uhr.
SOCIAL ENGAGEMENT